New therapeutic agents targeting the epidermal growth factor receptor.

Suppr

超能文献

作者信息

Baselga J

机构信息

Vall d'Hebron Hospital, Barcelona, Spain.

出版信息

J Clin Oncol. 2000 Nov 1;18(21 Suppl):54S-9S.

PMID:11060328

Abstract

摘要

相似文献

New therapeutic agents targeting the epidermal growth factor receptor.

J Clin Oncol. 2000 Nov 1;18(21 Suppl):54S-9S.

Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.

Cancer. 2005 Jun 15;103(12):2435-46. doi: 10.1002/cncr.21123.

Targeting the epidermal growth factor receptor: a clinical reality.

J Clin Oncol. 2001 Sep 15;19(18 Suppl):41S-44S.

Pharmacogenetics of EGFR and VEGF inhibition.

Drug Discov Today. 2007 Dec;12(23-24):1054-60. doi: 10.1016/j.drudis.2007.10.016. Epub 2007 Nov 26.

New agents in development for breast cancer.

Curr Opin Obstet Gynecol. 2007 Feb;19(1):68-74. doi: 10.1097/GCO.0b013e328011e6a2.

Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.

Cancer Res. 2001 Jul 1;61(13):5090-101.

Monoclonal antibody blockade of the epidermal growth factor receptor in cancer therapy.

Cancer Chemother Biol Response Modif. 2001;19:339-52.

Molecular mechanisms and targeting of colorectal cancer.

Semin Oncol. 2005 Dec;32(6 Suppl 8):7-10. doi: 10.1053/j.seminoncol.2005.07.018.

Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor.

Oncology (Williston Park). 2003 Jun;17(6):819, 826-30, 833-4 passim.

The epidermal growth factor receptor as a target for therapy.

Cancer Cells. 1990 Oct;2(10):321-3.

引用本文的文献

Nanoparticle-mediated diagnosis, treatment, and prevention of breast cancer.

Nanoscale Adv. 2024 May 23;6(15):3699-3713. doi: 10.1039/d3na00965c. eCollection 2024 Jul 23.

Epidermal growth factor receptor (EGFR) inhibitor induced purpuric drug eruption: Three case reports.

Medicine (Baltimore). 2019 Nov;98(47):e18112. doi: 10.1097/MD.0000000000018112.

Diffuse Optical Monitoring of the Neoadjuvant Breast Cancer Therapy.

IEEE J Sel Top Quantum Electron. 2012 Jul;18(4):1367-1386. doi: 10.1109/JSTQE.2011.2177963. Epub 2011 Dec 2.

Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Gynecol Oncol. 2011 Sep;122(3):495-500. doi: 10.1016/j.ygyno.2011.05.040.

Rational use of cetuximab in the treatment of advanced non-small cell lung cancer.

Onco Targets Ther. 2009 Feb 18;2:251-60. doi: 10.2147/ott.s4761.

Prospect of anticancer therapy.

Cancer Res Treat. 2004 Apr;36(2):100-2. doi: 10.4143/crt.2004.36.2.100. Epub 2004 Apr 30.

Refinement of the population pharmacokinetic model for the monoclonal antibody matuzumab: external model evaluation and simulations.

Clin Pharmacokinet. 2009;48(7):477-87. doi: 10.2165/11313400-000000000-00000.

Nonlinear pharmacokinetics of therapeutic proteins resulting from receptor mediated endocytosis.

J Pharmacokinet Pharmacodyn. 2009 Jun;36(3):239-60. doi: 10.1007/s10928-009-9120-1. Epub 2009 Jun 25.

Molecularly targeted therapy for pediatric brain tumors.

J Neurooncol. 2005 Dec;75(3):335-43. doi: 10.1007/s11060-005-6765-5.

Targeting epidermal growth factor receptor in lung cancer.

Curr Oncol Rep. 2002 Jul;4(4):317-24. doi: 10.1007/s11912-002-0007-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验